A mood disorder characterized by persistent sadness, loss of interest, and low energy. Can affect daily life and require professional support.
This study aimed to evaluate the efficacy of psilocybin therapy in reducing symptoms of depression, burnout, and PTSD in frontline clinicians affected by the COVID-19 pandemic.
This study aims to explore the risks associated with psychedelic-assisted therapies (PATs) by evaluating potential adverse events (AEs) to develop a comprehensive and standardized assessment framework.
This review investigates the potential role of psychedelics in addressing Alzheimer’s disease and associated depression, focusing on their neurochemical effects and therapeutic mechanisms.